However, the BA-mediated transcriptional activities of NF-κB have caused massive controversies, namely, BA blocks NF-κB activity to inhibit cervical cancer [36], prostate cancer [26], and breast cancer [19]. Here, NFKB1 is linked to breast carcinoma.